Pipeline vital for Glaxo mood
Investors will be looking for details on how drug giant GlaxoSmithKline?s (GSK) pipeline is developing in Wednesday?s (22 Oct) interims. Some of the drug-maker?s products have been hit by competition in recent years and following...
21 October 2014
